Preclinical studies showed that anti-EGFR antibodies enhanced anti-tumor effects of irradiation, suggesting that combining immunotherapy to radiotherapy and chemotherapy may be successful in anti-tumor therapies for cancers exhibiting EGFR nuclear localization [111]. This evidence concerns the gene EGFR and neoplasm.